EUVIMEDEUVIMED entdecken
Leserbrief

Lenalidomide following whole‐brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy

Bhausaheb Bagal iD, Rup Sarma iD, Sayak Dey, Lingaraj Nayak iD, Avinash Bonda, Jayant Goda iD, Nehal Khanna, Archya Dasgupta, Sangeeta Kakoti, Abhishek Chatarjee, Hasmukh Jain iD, Sridhar Epari und 3 weitere

British Journal of Haematology · 2023

DOI: 10.1111/bjh.18659 ↗

Kurz gefasst

Leserbrief in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Bhausaheb Bagal und 14 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, Tata Memorial Centre, Mumbai, India. Hauptthemen laut MEDLINE: Lymphoma, Non-Hodgkin, Central Nervous System Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Non-HodgkinCentral Nervous System NeoplasmsHumansLenalidomideRituximabCentral Nervous SystemBrainAntineoplastic Combined Chemotherapy Protocols

Substanzen

LenalidomideRituximab

Autor:innen und Institutionen

  • Medical Oncology, Tata Memorial Centre, Mumbai, India.
  • Homi Bhabha National Institute, Mumbai, India.
  • Radiation Oncology, Tata Memorial Centre, Mumbai, India.
  • Pathology, Tata Memorial Centre, Mumbai, India.

ORCID-Profile: Bhausaheb Bagal, Rup Sarma, Lingaraj Nayak, Jayant Goda, Hasmukh Jain, Manju Sengar, Tejpal Gupta

Zitieren

APA

Bagal, B., Sarma, R., Dey, S., Nayak, L., Bonda, A., Goda, J., Khanna, N., Dasgupta, A., Kakoti, S., Chatarjee, A., Jain, H., Epari, S., Laskar, S., Sengar, M., & Gupta, T. (2023). Lenalidomide following whole‐brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy. British Journal of Haematology. https://doi.org/10.1111/bjh.18659

Vancouver

Bagal B, Sarma R, Dey S, Nayak L, Bonda A, Goda J, et al. Lenalidomide following whole‐brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy. British Journal of Haematology. 2023. doi:10.1111/bjh.18659

BibTeX
@article{Bagal2023,
  author = {Bagal, Bhausaheb and Sarma, Rup and Dey, Sayak and Nayak, Lingaraj and Bonda, Avinash and Goda, Jayant and Khanna, Nehal and Dasgupta, Archya and Kakoti, Sangeeta and Chatarjee, Abhishek and Jain, Hasmukh and Epari, Sridhar and Laskar, Siddhartha and Sengar, Manju and Gupta, Tejpal},
  title = {Lenalidomide following whole‐brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy},
  journal = {British Journal of Haematology},
  year = {2023},
  doi = {10.1111/bjh.18659}
}
Kostenlos starten →